Tech Company Financing Transactions
NuVision Funding Round
MEIF Proof of Concept & Early Stage Fund, Mercia's EIS Funds and Midlands Engine Investment Fund participated in a $1.3 million venture round for NuVision. The funding round was announced on 3/9/2023.
Transaction Overview
Company Name
Announced On
3/9/2023
Transaction Type
Venture Equity
Amount
$1,324,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to accelerate the development of its first two products in advance of a Series A investment in the next 12 months.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
MediCity D6 Building Thane Road
Nottingham, NG90 6BH
UK
Nottingham, NG90 6BH
UK
Phone
Website
Email Address
Overview
NuVision is an expert team of scientific, clinical and insustry professionals dedicated to building innovative ocular biotherapies. Our work is rooted in our values. NuVision was founded in 2015 based on 15 years of translational research at the University of Nottingham. Research and innovation are still at our core as we continue to develop new technologies. We're building our portfolio of ocular biotherapies to ensure no patient goes without immediate access to treatment.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Noel Waters
Co-Founder
Harminder Dua
Co-Founder
Andrew Hopkinson
Browse more venture capital transactions:
Prev: 3/9/2023: Iktos venture capital transaction
Next: 3/9/2023: Cerebelly venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are derived from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs